LSE - Delayed Quote GBp
Creo Medical Group PLC (CREO.L)
At close: October 25 at 3:30 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-21,600.00
-21,600.00
-24,900.00
-26,011.00
-16,280.00
--
Investing Cash Flow
-18,300.00
-18,300.00
-6,000.00
-7,843.00
-20,967.00
--
Financing Cash Flow
29,800.00
29,800.00
400.00
31,993.00
1,326.00
--
End Cash Position
3,000.00
3,000.00
13,100.00
43,534.00
45,092.00
--
Capital Expenditure
-1,600.00
-1,600.00
-3,300.00
-6,122.00
-576.00
--
Issuance of Capital Stock
31,700.00
31,700.00
--
34,208.00
159.00
--
Issuance of Debt
200.00
200.00
2,800.00
144.00
2,055.00
--
Repayment of Debt
-1,400.00
-1,400.00
-1,600.00
-1,844.00
-497.00
--
Repurchase of Capital Stock
-26.83
--
--
--
--
--
Free Cash Flow
-23,200.00
-23,200.00
-28,200.00
-32,133.00
-16,856.00
--
12/31/2019 - 12/9/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VIVE Viveve Medical, Inc.
0.0005
+25.00%
SEQUA.BR Sequana Medical NV
0.9900
+2.06%
AIMD Ainos, Inc.
0.5600
+3.74%
SN.L Smith & Nephew plc
1,088.00
-3.03%
AEMD Aethlon Medical, Inc.
0.3750
+1.35%
QSI Quantum-Si incorporated
0.7450
-3.93%
TELA TELA Bio, Inc.
2.8600
+10.85%
PODD Insulet Corporation
233.63
-1.68%
PACB Pacific Biosciences of California, Inc.
1.7700
+2.91%
MDT Medtronic plc
90.59
-0.44%